Vericel

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vericel and other ETFs, options, and stocks.

About VCEL

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. 

CEO
Dominick C. Colangelo
CEODominick C. Colangelo
Employees
398
Employees398
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1989
Founded1989
Employees
398
Employees398

VCEL Key Statistics

Market cap
2.99B
Market cap2.99B
Price-Earnings ratio
91.61
Price-Earnings ratio91.61
Dividend yield
—
Dividend yield—
Average volume
1.21M
Average volume1.21M
High today
$59.57
High today$59.57
Low today
$57.75
Low today$57.75
Open price
$57.88
Open price$57.88
Volume
829.41K
Volume829.41K
52 Week high
$59.75
52 Week high$59.75
52 Week low
$28.95
52 Week low$28.95

Stock Snapshot

As of today, Vericel(VCEL) shares are valued at $58.65. The company's market cap stands at 2.99B, with a P/E ratio of 91.61.

As of 2026-11-18, Vericel(VCEL) stock has fluctuated between $57.75 and $59.57. The current price stands at $58.65, placing the stock +1.6% above today's low and -1.5% off the high.

The Vericel(VCEL)'s current trading volume is 829.41K, compared to an average daily volume of 1.21M.

During the past year, Vericel(VCEL) stock moved between $28.95 at its lowest and $59.75 at its peak.

During the past year, Vericel(VCEL) stock moved between $28.95 at its lowest and $59.75 at its peak.

VCEL News

Investing.com 5h
Vericel at Stephens conference: strong quarter, cautious 2027 view - Investing.com

...

Vericel at Stephens conference: strong quarter, cautious 2027 view - Investing.com
TipRanks 3d
Vericel Earnings Call Signals Broad Growth and Stronger Profits

Vericel Corporation ((VCEL)) has held its Q3 earnings call. Read on for the main highlights of the call. Vericel’s earnings call conveyed strong positive momen...

Simply Wall St 7d
Vericel Raised Guidance, Is The Upside Already Priced In?

Vericel (VCEL) has just posted third quarter results that showed higher revenue and net income compared with a year earlier, raised full year sales guidance, an...

Vericel Raised Guidance, Is The Upside Already Priced In?

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

More VCEL News

Simply Wall St 7d
Vericel's Earnings May Just Be The Starting Point

Vericel Corporation's ( ) strong earnings report was rewarded with a positive stock price move. We did some digging and found some further encouraging factors t...

Vericel's Earnings May Just Be The Starting Point

People also own

Based on the portfolios of people who own VCEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.